Navigation Links
Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field
Date:11/9/2009

WESTON, Mass., Nov. 9 /PRNewswire/ -- Groundbreaking articles in current issues of Journal of Opioid Management, for the first time explore, in depth, the emergence of cannabinoid medicine, its challenges for health care providers and its potential benefits for patients.

In these important articles, University of Washington authors, Sunil Aggarwal, PhD who is a member of the prestigious Medical Scientist Training Program and who conducted the article's research and Gregory T. Carter, MD, nationally recognized expert in the field of pain management, lead their team in taking a fresh look at all aspects of cannabinoid medicines, including the cannabinoid botanical marijuana, from the historical perspective and clinical evidence base for its use to the legal ramifications. In the second article, they offer a chart review examination of the treatment with medical cannabis of 139 chronic pain patients in the state of Washington.

As the authors point out, there is a near complete absence of education about cannabinoid medicine at any level of medical training despite the fact the Institute of Medicine concluded, after reviewing relevant scientific literature including dozens of works documenting marijuana's therapeutic value, that nausea, appetite loss, pain, and anxiety are all afflictions of wasting and all can be mitigated by the drug safely and with minimal toxicity. The research also shows that cannabinoid medicines have particular application for patients intolerant or refractory of opioid therapies for pain management.

The authors conclude that while cannabis is neither a miracle drug nor the answer to everyone's ills, the evidence suggests that physicians and medical students should make an extra effort to educate themselves in the art and science of cannabinoid medicine.

To purchase a reprint of Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions Sunil K. Aggarwal, PhD; Gregory T. Carter, MD, MS; Mark D. Sullivan, MD, PhD; Craig ZumBrunnen, PhD; Richard Morrill, PhD; Jonathan D. Mayer, PhD click this link http://tinyurl.com/ydqwtd2

To purchase a reprint of Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State Sunil K. Aggarwal, PhD, MD Candidate; Gregory T. Carter, MD, MS; Mark D. Sullivan, MD, PhD; Craig ZumBrunnen, PhD; Richard Morrill, PhD; Jonathan D. Mayer, PhD click this link http://tinyurl.com/y9yk9zq .

Journal of Opioid Management, a professional, peer-reviewed publication is designed to meet the challenge faced by physicians as they prescribe powerful, quality-of-life enhancing painkillers to their patients. Filling a long standing gap in medical literature, it addresses all aspects of opioid use and safe management and does so at a time when the federal spotlight has been switched on to the rising problem of abuse and addiction tied to these prescription painkillers.

Journal of Opioid Management has become the unchallenged journal of record for those in the field today. For more information about the journal, visit http://www.opioidmanagement.com . To subscribe to the online edition please visit http://ejournal.opioidmanagement.com or call the circulation department at 781-899-2702 ext 108.

    Contact: Richard A. Devito, Jr.
    Journal of Opioid Management
    781-899-2702 Ext. 107
    radjr@pnpco.com

SOURCE Journal of Opioid Management


'/>"/>
SOURCE Journal of Opioid Management
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)
2. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
3. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
4. Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting
5. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
6. Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
7. DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
8. Watson to Present at Credit Suisse Healthcare Conference
9. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
10. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
11. BD to Present at Investor Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Medivir AB (Nasdaq ... a new Board of Directors that will be submitted ... Committee comprises representatives of the company,s three largest shareholders ... who have accepted a seat on the Nomination Committee, ... the 2016-2017 Nomination Committee was as follows:  ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... 2017 ITL Limited, ( ASX: ITD ), an innovative ... half year ended 31 December 2016 compared with the previous corresponding ... be viewed here . Highlights ... 104%) Earnings per share of 2.2 cents (Dec ... (Dec 2015: $15.7m; up 11%) Profit before tax ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will be celebrated this ... Education Policy Center Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek ... winner is the Center for American Progress (CAP), for its report, Lessons From State ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... media outlet with a clinician-based audience, will be participating in Rare Disease Day ... in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and ...
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Los ... two episodes of WE TV’s “Mama June: From Not to Hot,” which will begin ... notable, “Mama” June Shannon, known to millions from the 2012 reality television series, “Here ...
(Date:2/23/2017)... Lawn, NJ (PRWEB) , ... February 23, 2017 ... ... specializing in thought leadership , media relations, content marketing, social media management, ... With several clients already in the state and in nearby New Hampshire, Massachusetts ...
(Date:2/23/2017)... California (PRWEB) , ... February 23, 2017 , ... ... Sports Development will host a diverse symposium on “Doping in Sport: ... Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be held ...
Breaking Medicine News(10 mins):